All In Biotech

Drug Trial Radar · NCT07245927

Post-registration Trial of the Non-immunogenic Staphylokinase in Massive Pulmonary Embolism

An Open, Prospective, Non-interventional, Multicentre, Controlled Study of Safety and Efficacy of the Thrombolysis With the Non-immunogenic Staphylokinase in Patients With Massive Pulmonary Embolism (FORPE Registry)

Last checked: Nov 20, 2026Latest source record: Jul 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

20,000

Planned (sponsor's estimate)

Start

Jun 1, 2025

Primary completion

Oct 31, 2027

Study completion Dec 31, 2027

Sponsor

Lead sponsor
Supergene, LLCIndustry
Sponsor type
Industry
Collaborators
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
First posted
Nov 24, 2025

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of FORPE Registry is to study the safety and efficacy of the non-immunogenic staphylokinase in patients with massive pulmonary embolism in routine clinical practice.

Conditions

  • Pulmonary Embolism Acute Massive

Interventions

  • Non-immunogenic staphylokinasenon-immunogenic staphylokinase 15 mg as a single intravenous bolus Other Names: Fortelyzin®Drug

    Non-immunogenic staphylokinase 15 mg as a single intravenous bolus

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. All-cause mortalityTime frame: day 7 after drug administration

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Belgorod Regional Clinical Hospital of St. Joseph

    Belgorod, Russia · Recruiting

  • Kuzbass Cardiology center

    Kemerovo, Russia · Recruiting

  • Center of Neurology and Cardiology

    Kirov, Russia · Recruiting

  • Lipetsk City Hospital No. 4 "Lipetsk-Med"

    Lipetsk, Russia · Recruiting

  • E.I. Chazov National Medical Research Center of Cardiology

    Moscow, Russia · Recruiting

  • F.I. Inozemtsev City Clinical Hospital

    Moscow, Russia · Recruiting

  • Moscow Multidisciplinary Clinical Center "Kommunarka"

    Moscow, Russia · Recruiting

  • S.P. Botkin City Clinical Hospital

    Moscow, Russia · Recruiting

  • S.S. Yudin City Clinical Hospital

    Moscow, Russia · Recruiting

  • N.A. Semashko Nizhny Novgorod Regional Clinical Hospital

    Nizhny Novgorod, Russia · Recruiting

  • G.A. Zakharyin Clinical hospital №6

    Penza, Russia · Recruiting

  • V.P. Polyakov Samara Regional Clinical Cardiology Dispensary

    Samara, Russia · Recruiting

  • Tver Regional Clinical Hospital

    Tver', Russia · Recruiting

  • City Clinical Hospital of Emergency medicine №25

    Volgograd, Russia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.